- Home
- AQMS vs CASI Comparison
AQMS vs CASI Comparison
Compare AQMS & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQMS
- CASI
- Stock Information
- Founded
- AQMS 2014
- CASI 1991
- Country
- AQMS United States
- CASI China
- Employees
- AQMS N/A
- CASI N/A
- Industry
- AQMS Metal Fabrications
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- AQMS Industrials
- CASI Health Care
- Exchange
- AQMS Nasdaq
- CASI Nasdaq
- Market Cap
- AQMS 24.2M
- CASI 24.9M
- IPO Year
- AQMS 2015
- CASI 1996
- Fundamental
- Price
- AQMS $7.40
- CASI $1.35
- Analyst Decision
- AQMS Buy
- CASI Strong Buy
- Analyst Count
- AQMS 1
- CASI 1
- Target Price
- AQMS $12.00
- CASI $4.00
- AVG Volume (30 Days)
- AQMS 4.3M
- CASI 28.4K
- Earning Date
- AQMS 11-12-2025
- CASI 11-28-2025
- Dividend Yield
- AQMS N/A
- CASI N/A
- EPS Growth
- AQMS N/A
- CASI N/A
- EPS
- AQMS N/A
- CASI N/A
- Revenue
- AQMS N/A
- CASI $31,564,000.00
- Revenue This Year
- AQMS N/A
- CASI N/A
- Revenue Next Year
- AQMS $550.00
- CASI N/A
- P/E Ratio
- AQMS N/A
- CASI N/A
- Revenue Growth
- AQMS N/A
- CASI 36.64
- 52 Week Low
- AQMS $3.37
- CASI $1.09
- 52 Week High
- AQMS $39.40
- CASI $5.95
- Technical
- Relative Strength Index (RSI)
- AQMS 46.54
- CASI 37.81
- Support Level
- AQMS $6.54
- CASI $1.30
- Resistance Level
- AQMS $11.48
- CASI $1.46
- Average True Range (ATR)
- AQMS 1.50
- CASI 0.15
- MACD
- AQMS -0.60
- CASI -0.02
- Stochastic Oscillator
- AQMS 7.01
- CASI 13.34
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.